BLOG
Blog
The Altascientist Issue 41: Immunomodulation Assessments for Clinical Trials–Sophisticated Bioanalytical Approaches to Support Complex Modalities
Issue 41 of The Altascientist explores immunomodulators, bioanalytical methods, and their biomarkers. Learn about immunotherapy trials and their PK/PD endpoints.
Blog
Case Study: Innovative Nanosuspension Approach to Maximize API Potency in Preclinical Formulation Development
Altasciences helped a client develop a robust preclinical formulation prototype at the maximum potency for their API BSC Class II compound.
Blog
Case Study: How to Evaluate Human Abuse Potential (HAP) for CNS Drugs
Altasciences supported a client with HAP studies for the development of a novel analgesic, mirogabalin, currently marked in Japan, Korea, Taiwan, and China.
Blog
Inside The Altascientist Issue 33: CNS Drug Development – Integrated Solutions Lessen Complexity
Issue 33 of The Altascientist investigates the benefits of integrated drug development solutions for the ever-increasing world of CNS therapeutics.
Blog
Internships at Altasciences: Q&A With Our Summer Interns
Altasciences’ interns reflect on their experience and what they’ve learned.
Blog
How Improving Diversity Can Benefit Clinical Trials
Representation and inclusion of various minority groups is crucial for medical research. Discover how drug developers, researchers, and regulators are ensuring this happens.